Abstract
Previous studies have shown that both copper (Cu) and vascular endothelial growth factor (VEGF) reduce the size of hypertrophic cardiomyocytes, but the Cu-induced regression is VEGF dependent. Studies in vivo have shown that hypertrophic cardiomyopathy is associated with a depression in cytochrome c oxidase (COX) activity, which could be involved in VEGF-mediated cellular function. The present study was undertaken to test the hypothesis that COX is a determinant factor in Cu-induced regression of cardiomyocyte hypertrophy. Primary cultures of neonatal rat cardiomyocytes were treated with phenylepherine (PE) at a final concentration of l00 μM in cultures for 48 h to induce cell hypertrophy. The hypertrophic cells were then treated with Cu sulfate at a final concentration of 5 μM in cultures for 24 h with a concomitant presence of PE to examine the effect of Cu on the regression of cardiomyocyte hypertrophy. Cell size changes were determined by flow cytometry, protein content, and molecular markers. Gene silencing was applied to study the effect of COX activity change on the regression of cardiomyocyte hypertrophy. PE treatment decreased COX activity in hypertrophic cardiomyocytes, and Cu addition restored the activity along with the regression of cell hypertrophy. Gene silencing using siRNA targeting COX-I significantly inhibited COX activity and blocked the Cu-induced regression of cell hypertrophy. VEGF alone also restored COX activity; but under the condition of COX inhibition by gene silencing, VEGF-induced regression of cell hypertrophy was suppressed. This study demonstrates that both Cu and VEGF can restore COX activity that is depressed in hypertrophic cardiomyocytes, and COX plays a determinant role in both Cu- and VEGF-induced regression of cardiomyocyte hypertrophy.
Similar content being viewed by others
References
Jiang, Y., Reynolds, C., Xiao, C., Feng, W., Zhou, Z., Rodriguez, W., et al. (2007). Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in mice. Journal of Experimental Medicine, 204, 657–666.
Zhou, Y., Jiang, Y., & Kang, Y. J. (2008). Copper reverses cardiomyocyte hypertrophy through vascular endothelial growth factor-mediated reduction in the cell size. Journal of Molecular and Cellular Cardiology, 45, 106–117.
Zhou, Y., Bourcy, K., & Kang, Y. J. (2009). Copper-induced regression of cardiomyocyte hypertrophy is associated with enhanced vascular endothelial growth factor receptor-1 signalling pathway. Cardiovascular Research, 84, 54–63.
Calhoun, M. W., Thomas, J. W., & Gennis, R. B. (1994). The cytochrome oxidase superfamily of redox-driven proton pumps. Trends in Biochemical Sciences, 19, 325–330.
Iwata, S. (1998). Structure and function of bacterial cytochrome c oxidase. Journal of Biochemistry, 123, 369–375.
Poyton, R. O., & McEwen, J. E. (1996). Crosstalk between nuclear and mitochondrial genomes. Annual Review of Biochemistry, 65, 563–607.
Abramson, J., Svensson-Ek, M., Byrne, B., & Iwata, S. (2001). Structure of cytochrome c oxidase: a comparison of the bacterial and mitochondrial enzymes. Biochimica et Biophysica Acta, 1544, 1–9.
Yoshikawa, S., Shinzawa-Itoh, K., & Tsukihara, T. (2000). X-ray structure and the reaction mechanism of bovine heart cytochrome c oxidase. Journal of Inorganic Biochemistry, 82, 1–7.
Yoshikawa, S. (2005). Reaction mechanism and phospholipid structures of bovine heart cytochrome c oxidase. Biochemical Society Transactions, 33, 934–937.
Poyton, R. O., Goehring, B., Droste, M., Sevarino, K. A., Allen, L. A., & Zhao, X. J. (1995). Cytochrome-c oxidase from Saccharomyces cerevisiae. Methods in Enzymology, 260, 97–116.
Geier, B. M., Schagger, H., Ortwein, C., Link, T. A., Hagen, W. R., Brandt, U., et al. (1995). Kinetic properties and ligand binding of the eleven-subunit cytochrome-c oxidase from Saccharomyces cerevisiae isolated with a novel large-scale purification method. European Journal of Biochemistry, 227, 296–302.
Tsukihara, T., Aoyama, H., Yamashita, E., Tomizaki, T., Yamaguchi, H., & Shinzawa-Itoh, K. (1996). The whole structure of the 13-subunit oxidized cytochrome c oxidase at 2.8 Å. Science, 272, 1136–1144.
Barrientos, A., Barros, M. H., Valnot, I., Rotig, A., Rustin, P., & Tzagoloff, A. (2002). Cytochrome oxidase in health and disease. Gene, 286, 53–63.
Das, J., Miller, S. T., & Stern, D. L. (2004). Comparison of diverse protein sequences of the nuclear-encoded subunits of cytochrome c oxidase suggests conservation of Structure underlies evolving functional sites. Molecular Biology and Evolution, 21, 1572–1582.
Tsukihara, T., Aoyama, H., Yamashita, E., Tomizaki, T., Yamaguchi, H., & Shinzawa-Itoh, K. (1995). Structures of metal sites of oxidized bovine heart cytochrome c oxidase at 28 A. Science, 269, 1069–1074.
Zeng, H. W., Saari, J. T., & Johnson, W. T. (2007). Copper deficiency decreases complex IV but not complex I, II, III, or V in the mitochondrial respiratory chain in rat heart. Journal of Nutrition, 137, 14–18.
Johnson, W. T., & Brown-borg, H. M. (2006). Cardiac cytochrome c oxidase deficiency occurs during late postnatal development in progeny of copper-deficient rats. Experimental Biology and Medicine, 231, 172–180.
Prohaska, J. R. (1983). Changes in tissue growth, concentrations of copper, iron, cytochrome oxidase and superoxide dismutase subsequent to subsequent to dietary or genetic copper deficiency in mice. Journal of Nutrition, 113, 2148–2158.
Prohaska, J. R. (1991). Changes in Cu, Zn-superoxide dismutase, cytochrome c oxidase, glutathione peroxidase and glutathione transferase activities in copper-deficient mice and rats. Journal of Nutrition, 121, 355–363.
Johnson, W. T., Dufault, S. N., & Thomas, A. C. (1993). Platelet cytochrome c oxidase is an indicator of copper status in rats. Nutrition research, 13, 1153–1162.
Johnson, W. T., & Anderson, C. M. (2008). Cardiac cytochrome c oxidase activity and contents of subunits 1 and 4 Are altered in offspring by low prenatal copper intake by rat dams. Journal of Nutrition, 138, 1269–1273.
Hoffmann, P., Richards, D., Heinroth-Hoffmann, I., Mathias, P., Wey, H., & Toraason, M. (1995). Arachidonic acid disrupts calcium dynamics in neonatal rat cardiac myocytes. Cardiovascular Research, 30, 889–898.
Siddiqui, R. A., Shaikh, S. R., Kovacs, R., Stillwell, W., & Zaloga, G. (2004). Inhibition of phenylephrine-induced cardiac hypertrophy by docosahexaenoic acid. Journal of Cellular Biochemistry, 92, 1141–1159.
Barron, M., Gao, M., & Lough, J. (2000). Requirement for BMP and FGF signaling during cardiogenic induction in non-precardiac mesoderm is specific, transient, and cooperative. Developmental Dynamics, 218, 383–393.
Yoshioka, J., Prince, R. N., Huang, H., Perkins, S. B., Cruz, F. U., & Macgillivray, C. (2005). Cardiomyocyte hypertrophy and degradation of connexin43 through spatially restricted autocrine/paracrine heparin- binding EGF. Proceedings of the National Academy of Sciences of the United States of America, 102, 10622–10627.
Venditti, C. P., Harris, M. C., Huff, D., Peterside, I., Munson, D., & Weber, H. S. (2004). Congenital cardiomyopathy and pulmonary hypertension: another fatal variant of cytochrome-c oxidase deficiency. Journal of Inherited Metabolic Disease, 27, 735–739.
Medeiros, D. M., & Jennings, D. (2002). Role of copper in mitochondrial biogenesis via interaction with ATP synthase and cytochrome c oxidase. Journal of Bioenergetics and Biomembranes, 34, 389–395.
Goffart, S., Kleist-Retzowa, J. C., & Wiesnera, R. J. (2004). Regulation of mitochondrial proliferation in the heart: power-plant failure contributes to cardiac failure in hypertrophy. Cardiovascular Research, 64, 198–207.
Chen, H., Huang, X. N., Stewart, A. F. R., & Sepulveda, J. L. (2004). Gene expression changes associated with fibronectin-induced cardiac myocyte hypertrophy. Physiological genomics, 18, 273–283.
Kuo, W. W., Chu, C. Y., Wu, C. H., Lin, J. A., Liu, J. Y., & Ying, T. H. (2005). The profile of cardiac cytochrome c oxidase (COX) expression in an accelerated cardiac-hypertrophy model. Journal of Biomedical Science, 12, 601–610.
Rae, T. D., Schmidt, P. J., Pufahl, R. A., Culotta, V. C., & O’Halloran, T. V. (1999). Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase. Science, 284, 805–808.
Acknowledgments
The authors thank Xiaohe Chen and Shengfu Li for technical support. This work was supported in part by West China Hospital and Sichuan University and by US National Institutes of Health [HL63760 to YJK].
Author information
Authors and Affiliations
Corresponding author
Additional information
Xiao Zuo and Huiqi Xie made equal contributions to this study.
Rights and permissions
About this article
Cite this article
Zuo, X., Xie, H., Dong, D. et al. Cytochrome c Oxidase is Essential for Copper-Induced Regression of Cardiomyocyte Hypertrophy. Cardiovasc Toxicol 10, 208–215 (2010). https://doi.org/10.1007/s12012-010-9080-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12012-010-9080-0